Femasys (FEMY) Convertible Debt (2023 - 2025)
Femasys posted quarterly Convertible Debt of $3.2 million for Q4 2025, down 37.28% on a QoQ basis from $5.1 million in Q3 2024.
Femasys (FEMY) has 3 years of Convertible Debt data on file, last reported at $3.2 million in Q4 2025.
- For the quarter ending Q4 2025, Convertible Debt changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2025 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $3.2 million, changed N/A from the prior year.
- Convertible Debt for Q4 2025 stood at $3.2 million, down from $5.1 million in the prior quarter.
- Across five years, Convertible Debt topped out at $5.1 million in Q3 2024 and bottomed at $3.2 million in Q4 2025.
- The 3-year median for Convertible Debt is $4.5 million (2024), against an average of $4.3 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 4.76 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | 4.26 Mn |